Welcome to our dedicated page for Waterdrop American news (Ticker: WDH), a resource for investors and traders seeking the latest updates and insights on Waterdrop American stock.
Waterdrop Inc. reports recurring developments for its NYSE-listed American depositary shares and its technology platform for insurance and healthcare services. Company news centers on unaudited quarterly and fiscal results, insurance-related revenue, cash dividends, ADS repurchases, and annual Form 20-F reporting.
Operational updates also cover Waterdrop Medical Crowdfunding, including risk-control and donor-transparency systems, and the E-Find Platform, the company’s digital clinical trial solution for patient enrollment and drug-patient matching. Product and technology updates include insurance plan launches, data infrastructure, automated review tools, and medical knowledge graph applications.
On June 5, 2024, Waterdrop (NYSE: WDH) reported Q1 2024 financial results. The company achieved revenue of RMB 704.7 million, a 16.3% year-on-year increase, and a net profit of RMB 80.6 million, up 62.2%. This marks nine consecutive profitable quarters. Operating expenses decreased to 46.4% of revenue. The insurance business saw a 13.1% increase in revenue to RMB 607 million, with life insurance representing 56.4% of the long-term product mix. Waterdrop Medical Crowdfunding raised RMB 63.8 billion, despite an operating loss of RMB 32.2 million. The company also saw 7.3% growth in healthcare-related services revenue, reaching RMB 25.3 million.
Waterdrop Inc. (NYSE: WDH) reported its unaudited financial results for Q1 2024. The company achieved a net profit of RMB80.6 million, a 36.5% growth quarter-over-quarter. Operating revenue increased by 16.3% year over year to RMB704.7 million. First-year premiums from insurance rose by 3.7% to RMB1,754.5 million, with life insurance products contributing 56.4% compared to 46.5% last year. The company also saw growth in its medical crowdfunding platform, accumulating RMB63.8 billion in donations. Operating expenses increased by 10.5% to RMB658.3 million, with notable rises in operating costs and sales and marketing expenses. However, general and administrative expenses decreased by 7.1%. The company's cash and equivalents stood at RMB3,484.4 million as of March 31, 2024.
Waterdrop's CEO highlighted the company's sustained profitability and strategic initiatives in the insurance and healthcare sectors. The company aims to enhance its digital clinical trial services and expand its market presence while maintaining a focus on core technology competitiveness. The press release emphasized the company's mission to provide customized, cost-effective products and services.
Waterdrop (NYSE: WDH) will release its Q1 2024 financial results on June 5, 2024, before U.S. markets open. The results pertain to the quarter ending March 31, 2024. A conference call to discuss these results will be held on the same day at 8:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time). Dial-in details include numbers for international, U.S. toll-free, Hong Kong, and Mainland China participants, with options for Chinese and English lines. Replays will be available until June 12, 2024. Live and archived webcasts will be provided on Waterdrop's investor relations website.
Waterdrop Inc. released its 2023 annual report, showcasing sustained profitability and impressive growth in innovative businesses. The company recorded net operating revenue of RMB 2.63 billion, net profit of RMB 167 million, and operating cash flow of RMB 407 million. Waterdrop Insurance Marketplace reported a first-year premium of RMB 7.109 billion, collaborated with 101 insurance companies, and offered 1,357 online insurance products to 115.3 million customers. The company acquired Shenlanbao, developed a large language model 'ShuishouGPT', and ventured into digital clinical trial solutions, achieving 69% revenue growth in 2023.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.